--(www.USEquityNews.com)-- 05/02/2008 - Healthcare industry alert provided by U.S. Equity News. Human BioSystems (OTCBB: HBSC) ("HBS"), a Silicon Valley-based biotech and bioenergy company, announced recently that it had partnered with the principals of Dairy Development Group to form Environmental BioMass Energy, Inc. ("EBE") to produce renewable electrical energy from waste biomass such as cow manure. EBE now announces the signing of a term sheet for a commitment to provide financing of $66 million USD for a California-based biomass renewable energy generation project that will convert cow manure into 20 (net) megawatts of electricity, as well as steam, hot water and organic fertilizer. Mr. Len Chapman, CEO of EBE, stated, "The total capitalized cost for the project is estimated to be 72 million USD. Funding is dependent on satisfying the conditions of the term sheet which includes EBE obtaining all necessary permits and land to be ready for construction."
The Aristotle Corporation (NASDAQ: ARTL) announced today its results of operations for the quarter ended March 31, 2008. For the quarter ended March 31, 2008, net earnings applicable to common stockholders increased 20.5% to $2.8 million, or $.16 per diluted common share, compared to $2.4 million, or $.13 per diluted common share, for the quarter ended March 31, 2007 (weighted average common shares outstanding were 18.0 million for the first quarter of 2008 versus 17.5 million for the same period in 2007). Earnings before income taxes increased 8.9% to $8.0 million for the current quarter from $7.4 million for last year's quarter.
ev3 Inc. (NASDAQ: EVVV), a global endovascular device company, today reported financial results for its fiscal first quarter of 2008 and its revised financial guidance for 2008. As previously reported, ev3's net sales were $101.3 million in the first quarter of 2008 representing a 65% increase over the same quarter of the prior year and a 10% increase over the fourth quarter of 2007. The increase in net sales over the same quarter of the prior year was primarily attributable to the acquisition of FoxHollow. The sequential quarter increase in net sales was driven by growth in the pre-FoxHollow acquisition peripheral vascular business segment and the neurovascular business segment.
I-Flow Corporation (NASDAQ: IFLO) announced today that Regional Anesthesia revenues increased 18% for the first quarter of 2008 to a first quarter record $22.6 million compared to $19.1 million for the first quarter of 2007. Sales of its Acute Care products, which include Regional Anesthesia and AcryMed revenues, increased 21% for the first quarter of 2008 to $23.2 million compared to $19.1 million for the first quarter of 2007. Total revenue from continuing operations increased 17% versus the prior year. The loss from continuing operations narrowed to $0.5 million, or $0.02 per share, compared to a loss from continuing operations for the first quarter of 2007 of $2.2 million, or $0.09 per share.
About U.S. Equity News
U.S. Equity News provides information, resources and news services for investors of small-cap, micro-cap and emerging companies. U.S. Equity News distributes RSS news feeds and a free subscription-based newsletter available through its website at www.usequitynews.com.
U.S. Equity News is a financial news distribution service by Equity Solutions, Inc. (www.equityirsolutions.com) that provides a platform for public companies to disseminate important news to key Wall Street interest such as shareholders and new investors. Equity Solutions, Inc. can assist by providing an effective increase in the awareness of a public company's news, development and corporate story through its proprietary network and its financial portal. U.S. Equity News and its affiliates charge each client cash for news distribution and may take an equity position in the companies mentioned herein, please visit the disclaimer at www.USEquityNews.com.
